Following the merger of Firmenich und DSM, the Swiss-Dutch corporation DSM-Firmenich is to be established. As detailed in a press release, the new holding company will be based in Kaiseraugst in the canton of Aargau. It will operate from two headquarters in Kaiseraugst and Maastricht in the Netherlands. DSM-Firmenich will therefore become the leading creation and innovation partner for nutrition, beauty and well-being. In Switzerland, DSM already operates the DSM Sisseln site in the canton of Aargau, which is the largest production facility for vitamin E in the world.
The two CEOs of DSM, Geraldine Matchett and Dimitri de Vreeze, will be responsible for managing the holding company, while DSM Chairman Thomas Leysen will chair the Board of Directors. Firmenich President Patrick Firmenich will perform the role of Vice-President.
Up to the year 2026, the two companies see synergy potential amounting an adjusted EBITDA result of 350 million euros. That would include an annual increase in sales of 500 million euros, notably through the combination of DSM’s Food & Beverage division and Firmenich’s Taste & Beyond business. As a result, earnings per share could be in the double-digit range.
Sustainable organic sales growth is estimated at between 5 and 7 percent per year, with a medium-term adjusted EBITDA margin of 22 to 23 percent. Firmenich shareholders will hold a stake of 34.5 percent in DSM Firmenich overall, while 65.5 percent of the shares are to be held by DSM shareholders. The latter will also receive an additional 3.5 billion euros in cash.
This merger brings together two similarly orientated companies that each boast an innovation heritage extending back 125 years, as Patrick Firmenich, Chairman of the Supervisory Board at Firmenich, explains, before adding: “I am confident that for all stakeholders of the future DSM-Firmenich business, the most exciting times are still to come”.
